Tiny sensor may spot hidden diabetes risk in steroid users
NCT ID NCT07190378
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 23 times
Summary
This study looks at 250 adults who are starting steroid treatment for conditions like autoimmune diseases or inflammation. Researchers will use a continuous glucose monitor (CGM) worn for 14 days to see if it can detect steroid-induced diabetes earlier and more accurately than standard tests. The goal is to identify who is at risk and improve how this type of diabetes is diagnosed and managed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
Warsaw, Warsaw, 02-097, Poland
Conditions
Explore the condition pages connected to this study.